Literature DB >> 7809084

The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor.

H Fuchs1, R Wallich, M M Simon, M D Kramer.   

Abstract

The spirochete Borrelia burgdorferi is the causative agent of Lyme borreliosis (Lyme disease) and is transmitted to mammalian hosts by tick vectors. In humans, the bacteria induce a complex disease, which involves the skin, joints, heart, and nervous system. However, the pathogenic principles of this multisystem illness are far from being understood. To disseminate from the site of the tick bite and invade multiple organ sites, spirochetes have to penetrate normal tissue barriers, such as vascular basement membranes and other organized extracellular matrices. Substantial evidence from other invasive bacterial infections suggest that spirochetes may use endogenous or host-derived enzymes--in particular, proteinases--for this purpose. Here we show that B. burgdorferi binds human plasmin(ogen)--mainly via its outer cell surface lipoprotein A. Binding of plasminogen to spirochetal receptor leads to an accelerated formation of active plasmin in the presence of host-derived plasminogen activator. The cell-surface-associated plasmin cannot be regulated by the serum inhibitor alpha 2-antiplasmin and degrades high-molecular-weight glycoproteins, such as fibronectin. It is suggested that the acquisition of host-derived proteinase plasmin(ogen) contributes to the pathogenicity of B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7809084      PMCID: PMC45485          DOI: 10.1073/pnas.91.26.12594

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Characterization of Borrelia burgdorferi invasion of cultured endothelial cells.

Authors:  L E Comstock; D D Thomas
Journal:  Microb Pathog       Date:  1991-02       Impact factor: 3.738

2.  Fast and sensitive detection of protein and DNA bands by treatment with potassium permanganate.

Authors:  W Ansorge
Journal:  J Biochem Biophys Methods       Date:  1985-05

3.  New receptor for human plasminogen on gram positive cocci.

Authors:  M Ullberg; G Kronvall; B Wiman
Journal:  APMIS       Date:  1989-11       Impact factor: 3.205

Review 4.  Biochemical and biological aspects of the plasminogen activation system.

Authors:  M Mayer
Journal:  Clin Biochem       Date:  1990-06       Impact factor: 3.281

5.  Interaction between Borrelia burgdorferi and endothelium in vitro.

Authors:  A Szczepanski; M B Furie; J L Benach; B P Lane; H B Fleit
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

6.  Thrombolytic properties of staphylokinase.

Authors:  O Matsuo; K Okada; H Fukao; Y Tomioka; S Ueshima; M Watanuki; M Sakai
Journal:  Blood       Date:  1990-09-01       Impact factor: 22.113

Review 7.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

Review 8.  Human plasma proteinase inhibitors.

Authors:  J Travis; G S Salvesen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

9.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

10.  Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies.

Authors:  M D Kramer; U E Schaible; R Wallich; S E Moter; D Petzoldt; M M Simon
Journal:  Immunobiology       Date:  1990-11       Impact factor: 3.144

View more
  74 in total

Review 1.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Lyme disease-causing Borrelia species encode multiple lipoproteins homologous to peptide-binding proteins of ABC-type transporters.

Authors:  J A Kornacki; D B Oliver
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Binding of human plasminogen to Borrelia burgdorferi.

Authors:  L T Hu; G Perides; R Noring; M S Klempner
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.

Authors:  R Wallich; C Brenner; M D Kramer; M M Simon
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 5.  Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector.

Authors:  Faith Kung; Juan Anguita; Utpal Pal
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

6.  Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.

Authors:  B Wilske; U Busch; H Eiffert; V Fingerle; H W Pfister; D Rössler; V Preac-Mursic
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

Review 7.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  A novel mechanism for the acquisition of virulence by a human influenza A virus.

Authors:  H Goto; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 9.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

10.  Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.

Authors:  Sonja Grosskinsky; Melanie Schott; Christiane Brenner; Sally J Cutler; Peter Kraiczy; Peter F Zipfel; Markus M Simon; Reinhard Wallich
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.